|
|
Volumn 39, Issue 7, 2001, Pages 665-674
|
|
Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water
a
a
NONE
(India)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARSENIC;
DRINKING WATER;
PLACEBO;
UNITHIOL;
ADULT;
ARSENIC POISONING;
ARTICLE;
CHELATION;
CHRONIC TOXICITY;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG CAPSULE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEPATOMEGALY;
HUMAN;
KERATOSIS;
LIVER FUNCTION TEST;
LUNG DISEASE;
MALE;
MUSCLE WEAKNESS;
PIGMENTATION;
RANDOMIZED CONTROLLED TRIAL;
SINGLE BLIND PROCEDURE;
SKIN BIOPSY;
URINARY EXCRETION;
WATER CONTAMINATION;
ADULT;
ANTIDOTES;
ARSENIC;
ARSENIC POISONING;
CHELATING AGENTS;
CHELATION THERAPY;
CHRONIC DISEASE;
DRUG ADMINISTRATION SCHEDULE;
ENVIRONMENTAL EXPOSURE;
FEMALE;
HUMANS;
MALE;
PROSPECTIVE STUDIES;
SINGLE-BLIND METHOD;
SKIN DISEASES;
SPECTROPHOTOMETRY, ATOMIC;
TREATMENT OUTCOME;
UNITHIOL;
WATER POLLUTANTS, CHEMICAL;
WATER SUPPLY;
|
|
EID: 0035659765
PISSN: 07313810
EISSN: None
Source Type: Journal
DOI: 10.1081/CLT-100108507 Document Type: Article |
|
Times cited : (87)
|
|
References (40)
|
